Pharmacists are likely aware that Wegovy® (semaglutide) is now available in Australia. The PDL Professional Officers have received several incident reports involving patients being supplied
The Wrong Patient incident type is a subset of dispensing incidents that continue to be highly reported to PDL. This almost entirely preventable error occurs
The Pharmacy Board of Australia’s revised Guidelines on compounding of medicines, which will take effect from 1 October 2024, is a timely reminder of the
PDL is delighted to sponsor the new Pharmacists’ Support Service (PSS) John Coppock Pharmacist Wellbeing Award, honouring the significant contribution of John to the wellbeing
The following vacancies will occur as of the date of the next Annual General Meeting to be held on Thursday, 17 October 2024. One Director
Understanding the click method PDL has become aware of a number of adverse events and health consequences from the popularised method of OZEMPIC® (semaglutide) administration
When pharmacists receive regulatory notifications, a range of common misconceptions can cloud their perception and impede their ability to respond effectively. Among these misconceptions are
Social media has become part of everyday life for many people including pharmacists. It can also be harnessed by pharmacy businesses to improve engagement with
PDL is pleased to announce the winners of the 2024 PDL Student Grants. Congratulations to Yannee Liu (Vic), Aaron Stockwell (WA) and Riko Ngo (Vic).
The safety of a pharmacist’s patients should always be front of mind. Beyond a pharmacist’s clinical expertise, the culture within our healthcare settings significantly impacts
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.